Company Profile
Halozyme Therapeutics, Inc. Stock Price, News & Analysis
- Ticker:
- HALO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, HALO is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
69.62 USD (+0.91%)
Close
Last updated: June 23, 2026 at 00:00
8.26B USD
Market cap
Why the stock is moving
HALO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
HALO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, HALO is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
HALO follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, HALO sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Halozyme Therapeutics, Inc. (HALO)?
Halozyme Therapeutics, Inc. (HALO) most recently closed at 69.62 USD, a +0.91% move versus the previous session.
What is the market cap of Halozyme Therapeutics, Inc. (HALO)?
Halozyme Therapeutics, Inc. currently has a market capitalization of 8.26B USD on BioPharmSignal.
What does Halozyme Therapeutics, Inc. do?
HALO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is HALO stock listed?
Halozyme Therapeutics, Inc. (HALO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, HALO is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is Halozyme Therapeutics, Inc. targeting with Investors?
HALO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.